Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.
The uninsured rate has been cut in half, but Americans are sicker, and their life expectancy is stagnating. Doing more of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback